Christopher J. Recklitis, PhD, MPH, on The Risk of Suicide After a Cancer Diagnosis

2015 IPOS APOS World Congress of Psycho-Oncology
Tweet this page

Christopher J. Recklitis, PhD, MPH, of the Dana-Farber Cancer Institute, discusses what is known about suicide after cancer, the risks faced by prostate cancer patients within the first year after diagnosis, and challenges across the treatment trajectory

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.